Transine Therapeutics
Edit

Transine Therapeutics

https://www.transinetx.com/
Tags:BioTechDevelopmentITPlatformTechnologyWebsite
Transine Therapeutics is a private biotechnology company, headquartered in Cambridge-UK, focused on the development of a novel class of therapeutic RNAs that can upregulate protein expression with an unprecedented level of control and specificity: the SINEUPs®. Transine® pioneering technology is expected to offer an entirely unique mechanism of action for currently hard-to-treat diseases by massively extending the druggable proteome, enabling it to address diseases which have been beyond the reach of small molecules, conventional biologics or gene therapies.
Location: United Kingdom, England, Cambridge
Member count: 11-50
Total raised: $30.146309M
Founded date: 2020

Investors 2

Funding Rounds 2

DateSeriesAmountInvestorsDeal News
31.05.2022Seed$17.25091M-svhealthin...
03.06.2021Seed$12.895399...Dementia D...svhealthin...

Mentions in press and media 8

DateTitleDescriptionCategoryAuthorSource
31.05.2022Transine T...Transine Therapeutics, a Cambr...UK-finsmes.co...
31.05.2022Transine T...Cambridge, UK, 31 May 2022: Tr...--svhealthin...
05.07.2021Transine T...Transine Therapeutics appoints...--cambridgen...
05.07.2021Transine T...Dr Thirkettle is a seasoned li...--svhealthin...
03.06.2021Transine T...Transine Therapeutics, a Cambr...UK-finsmes.co...
02.06.2021Transine T...Transine Therapeutics closes e...--cambridgen...
02.06.2021Transine T...New company emerges from steal...--cambridgen...
02.06.2021Transine T...New Company emerges from steal...--svhealthin...